Literature DB >> 17716160

New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?

Si-Shen Feng1.   

Abstract

No substantial progress has really been observed during the past 50 years in fighting cancer, and the way we currently detect and treat cancer is similar to 30 years ago. Cancer nanotechnology will change the situation radically. Progress in developing nanoparticles of biodegradable polymers for new-concept chemotherapy is reviewed here by using the in vitro and in vivo experimental results obtained in my laboratory as a proof-of-concept demonstration. The prospects of using multifunctional nanoparticles for targeting, diagnosing, therapy delivery and result-reporting as a possible solution for cancer detection and treatment are also described. I believe that cancer will become curable using targeted and sustained chemotherapy by such nanoparticles at the earliest stage of disease. High efficacy and low side effects can be achieved, since high drug concentrations can be delivered selectively to the cancer cells, leaving healthy cells untouched. Thus, the required amount of the drug can be minimized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17716160     DOI: 10.2217/17435889.1.3.297

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  14 in total

Review 1.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2011-12-24       Impact factor: 15.470

2.  Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design.

Authors:  Simeon K Adesina; Scott A Wight; Emmanuel O Akala
Journal:  Drug Dev Ind Pharm       Date:  2013-09-23       Impact factor: 3.225

3.  The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Authors:  Melisa Dirchwolf; Jennifer L Dodge; Jane Gralla; Kiran M Bambha; Trevor Nydam; Kenneth W Hung; Hugo R Rosen; Sandy Feng; Norah A Terrault; Scott W Biggins
Journal:  Liver Transpl       Date:  2015-08       Impact factor: 5.799

4.  Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies.

Authors:  Simeon K Adesina; Alesia Holly; Gabriela Kramer-Marek; Jacek Capala; Emmanuel O Akala
Journal:  J Pharm Sci       Date:  2014-06-24       Impact factor: 3.534

5.  Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation.

Authors:  Gérrard Eddy Jai Poinern; Xuan Thi Le; Songhua Shan; Trevor Ellis; Stan Fenwick; John Edwards; Derek Fawcett
Journal:  Int J Nanomedicine       Date:  2011-09-28

Review 6.  Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives.

Authors:  Christiana M Neophytou; Andreas I Constantinou
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

Review 7.  Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.

Authors:  Madaswamy S Muthu; David Tai Leong; Lin Mei; Si-Shen Feng
Journal:  Theranostics       Date:  2014-03-26       Impact factor: 11.556

8.  Nano-encapsulated Tinospora cordifolia (Willd.) using poly (D, L-lactide) nanoparticles educe effective control in streptozotocin-induced type 2 diabetic rats.

Authors:  Ragavee Ambalavanan; Arul Daniel John; Asha Devi Selvaraj
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

9.  New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles.

Authors:  Nelly Mezzaroba; Sonia Zorzet; Erika Secco; Stefania Biffi; Claudio Tripodo; Marco Calvaruso; Ramiro Mendoza-Maldonado; Sara Capolla; Marilena Granzotto; Ruben Spretz; Gustavo Larsen; Sandra Noriega; Marianna Lucafò; Eduardo Mansilla; Chiara Garrovo; Gustavo H Marín; Gabriele Baj; Valter Gattei; Gabriele Pozzato; Luis Núñez; Paolo Macor
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

10.  Lipid-coated gold nanocomposites for enhanced cancer therapy.

Authors:  Ji Hee Kang; Young Tag Ko
Journal:  Int J Nanomedicine       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.